Lafontan M - Search Results

1

Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers.

Galitzky J, Taouis M, Berlan M, Rivière D, Garrigues M, Lafontan M. Galitzky J, et al. Among authors: lafontan m. Eur J Clin Invest. 1988 Dec;18(6):587-94. doi: 10.1111/j.1365-2362.1988.tb01272.x. Eur J Clin Invest. 1988. PMID: 2906290 Clinical Trial.

2

Alpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.

Lafontan M, Berlan M, Galitzky J, Montastruc JL. Lafontan M, et al. Am J Clin Nutr. 1992 Jan;55(1 Suppl):219S-227S. doi: 10.1093/ajcn/55.1.219s. Am J Clin Nutr. 1992. PMID: 1345885 Review.

3

Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy.

Berlan M, Montastruc JL, Lafontan M. Berlan M, et al. Among authors: lafontan m. Trends Pharmacol Sci. 1992 Jul;13(7):277-82. doi: 10.1016/0165-6147(92)90085-k. Trends Pharmacol Sci. 1992. PMID: 1354903 Review.

4

Thermogenic and lipolytic effect of yohimbine in the dog.

Galitzky J, Vermorel M, Lafontan M, Montastruc P, Berlan M. Galitzky J, et al. Among authors: lafontan m. Br J Pharmacol. 1991 Oct;104(2):514-8. doi: 10.1111/j.1476-5381.1991.tb12460.x. Br J Pharmacol. 1991. PMID: 1797315 Free PMC article.

5

Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women.

Berlan M, Galitzky J, Riviere D, Foureau M, Tran MA, Flores R, Louvet JP, Houin G, Lafontan M. Berlan M, et al. Among authors: lafontan m. Int J Obes. 1991 May;15(5):305-15. Int J Obes. 1991. PMID: 1885256

6

New tools for human fat cell alpha-2A adrenoceptor characterization. Identification on membranes and on intact cells using the new antagonist [3H]RX821002.

Galitzky J, Larrouy D, Berlan M, Lafontan M. Galitzky J, et al. Among authors: lafontan m. J Pharmacol Exp Ther. 1990 Jan;252(1):312-9. J Pharmacol Exp Ther. 1990. PMID: 1967647

7

Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.

Galitzky J, Senard JM, Lafontan M, Stillings M, Montastruc JL, Berlan M. Galitzky J, et al. Among authors: lafontan m. Br J Pharmacol. 1990 Aug;100(4):862-6. doi: 10.1111/j.1476-5381.1990.tb14105.x. Br J Pharmacol. 1990. PMID: 1976403 Free PMC article.

8

Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.

Valet P, Berlan M, Beauville M, Crampes F, Montastruc JL, Lafontan M. Valet P, et al. Among authors: lafontan m. J Clin Invest. 1990 Jan;85(1):291-5. doi: 10.1172/JCI114425. J Clin Invest. 1990. PMID: 2104880 Free PMC article.

9

Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.

Saulnier-Blache JS, Taouis M, Dauzats M, Uzan A, Berlan M, Lafontan M. Saulnier-Blache JS, et al. Among authors: lafontan m. J Pharmacol Exp Ther. 1989 Dec;251(3):1193-8. J Pharmacol Exp Ther. 1989. PMID: 2481031

10

Platelet alpha 2-adrenoceptors and adrenergic adipose tissue responsiveness after moderate hypocaloric diet in obese subjects.

Crampes F, Marceron M, Beauville M, Riviere D, Garrigues M, Berlan M, Lafontan M. Crampes F, et al. Among authors: lafontan m. Int J Obes. 1989;13(1):99-110. Int J Obes. 1989. PMID: 2539340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters